Stempeutics out licenses its stem cell product to Cipla for treating Diabetic Foot Ulcer
Under this agreement, Cipla will get the exclusive marketing rights for five years in India for DFU product with Stempeutics…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.